Skip to main content

Table 1 Respondent characteristics among general practitioners randomised to six versions (A-F)a of a vignette portraying a patient with an unfavourable cardiovascular risk profile

From: Decisions on statin therapy by patients’ opinions about survival gains: cross sectional survey of general practitioners

Group Mean age Proportion female Mean # of patients listed Specialty attainment
A 47 84/236 (36 %) 1222 149/237 (63 %)
B 48 77/211 (37 %) 1188 150/214 (70 %)
C 47 64/203 (32 %) 1242 138/203 (68 %)
D 48 85/225 (38 %) 1216 156/226 (69 %)
E 47 81/220 (37 %) 1175 139/220 (63 %)
F 47 78/208 (38 %) 1213 130/208 (63 %)
All Norwegian GPs n = 4,049b 49c 35%c 1182c 55%d
  1. aThe vignettes differed with respect to the survival gain the patient would require to consider simvastatin therapy worthwhile (A: 3 months, B: 6 months, C: 12 months, D: 2 years, E: 4 years, F: 8 years)
  2. bStatistics Norway (http://www.ssb.no accessed 24th of March 2011)
  3. c https://helsedirektoratet.no/Documents/Statistikk%20og%20analyse/Fastlegestatistikk/Fastlegestatistikk%20hovedtallsrapport-2010.pdf
  4. dhttp://www.legeforeningen.no/id/18 14.04.2011